Related Experiment Videos
Genotypic heterogeneity among Lewis negative individuals
A Elmgren1, L Rydberg, G Larson
1Department of Clinical Chemistry and Transfusion Medicine, Sahlgren's Hospital, Göteborg, Sweden.
Biochemical and Biophysical Research Communications
|October 29, 1993
Summary
A novel C to T mutation in the alpha (1,3/1,4) fucosyltransferase III (FT-III) gene is linked to Lewis a and b antigen synthesis. This genetic variant was predominantly found in Lewis negative individuals, suggesting a role in Lewis blood group expression.
Area of Science:
- Genetics
- Biochemistry
- Immunology
Background:
- The alpha (1,3/1,4) fucosyltransferase III (FT-III) gene is crucial for synthesizing Lewis a and Lewis b blood group antigens.
- Lewis blood group antigens play roles in various biological processes, including immune responses and pathogen binding.
Purpose of the Study:
- To identify genetic variations in the FT-III gene associated with Lewis antigen expression.
- To investigate the functional impact of identified mutations on FT-III enzyme activity and antigen synthesis.
Main Methods:
- DNA sequencing of the FT-III gene coding region.
- Restriction fragment length polymorphism (RFLP) analysis using NlaIII enzyme.
- Genotyping of individuals with known Lewis blood group phenotypes.
Main Results:
- A specific C to T mutation at nucleotide 314 in the FT-III gene was identified.
- This mutation creates a new NlaIII restriction site.
- The mutation was present in homozygous form in 5/18 Lewis negative individuals and absent in 22 Lewis positive individuals.
- Heterozygous individuals for this mutation were found in both Lewis negative (10/18) and Lewis positive (4/22) groups.
- The mutation results in a threonine to methionine amino acid substitution.
Conclusions:
- The identified C to T mutation in the FT-III gene is strongly associated with Lewis negative phenotypes.
- This genetic variation likely impairs the synthesis of Lewis a and b antigens.
- The findings contribute to understanding the genetic basis of Lewis blood group expression and its clinical implications.